Covered recipient · General Payments record
RAKCHHYA SHRESTHA
General Payments · PY2023–2024
$731.30
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $575.85 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $161.36 | 6 |
| ABBVIE INC. | $151.52 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $134.35 | 1 |
| SK Life Science, Inc. | $55.82 | 2 |
| Amgen Inc. | $27.67 | 1 |
| Teva Pharmaceuticals USA, Inc. | $26.29 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $125.00 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113850943 | CMS |
| ABBVIE INC. | $26.52 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113850949 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.84 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110509454 | CMS |
| Amgen Inc. | $27.67 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117683572 | CMS |
| Novartis Pharmaceuticals Corporation | $134.35 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087216447 | CMS |
| SK Life Science, Inc. | $28.76 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111833 | CMS |
| SK Life Science, Inc. | $27.06 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154111841 | CMS |
| Teva Pharmaceuticals USA, Inc. | $26.29 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151568407 | CMS |
| UCB, Inc. | $32.52 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328927 | CMS |
| UCB, Inc. | $30.49 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328931 | CMS |
| UCB, Inc. | $18.21 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328936 | CMS |
| UCB, Inc. | $25.11 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328941 | CMS |
| UCB, Inc. | $28.46 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328945 | CMS |
| UCB, Inc. | $26.57 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143328949 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.